Avista to make 3.7 times its money with sale of Arcadia Consumer Healthcare

Accounting for Arcadia proceeds and prior Fund 4 exits – Organogensis and MPI Research – the vehicle will have returned approximately $1.4bn to investors, according to an LP letter.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this